Patents by Inventor Thomas VASICEK

Thomas VASICEK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES
    Publication number: 20250241992
    Abstract: Compositions comprising satiety peptides (e.g., PYY, PYY(3-36), GLP-1, oxyntomodulin, and cholecystokinin) and DPP-IV inhibitors and methods of treating metabolic diseases with such compositions are provided.
    Type: Application
    Filed: February 28, 2025
    Publication date: July 31, 2025
    Inventors: Andres ACOSTA, Thomas VASICEK
  • PEPTIDE YY PHARMACEUTICAL FORMULATIONS, COMPOSITIONS, AND METHODS
    Publication number: 20250121033
    Abstract: Pharmaceutical compositions comprising PYY (e.g., PYY(3-36) and analogs and variants thereof), satiety peptides, satiety hormones, metabolic hormones, and methods of treating metabolic diseases with such compositions are provided. Aspects include methods of increasing a feeling of fullness in patients treated with pharmaceutical compositions comprising PYY, PYY(3-36), satiety peptides, satiety hormones, metabolic hormones, and analogs, receptor antagonists and variants thereof.
    Type: Application
    Filed: December 23, 2024
    Publication date: April 17, 2025
    Inventors: Andres ACOSTA, Thomas VASICEK, Beth Anne-Szkudlarek BROWN
  • COMPOSITIONS AND METHODS FOR ACTIVATING A NEURAL RECEPTOR
    Publication number: 20240342247
    Abstract: The invention provides compositions and methods for inducing activating a neural receptor. The compositions include a metabolic hormone, which can be used to provide treatment for an addiction or mood disorder in a subject.
    Type: Application
    Filed: July 8, 2022
    Publication date: October 17, 2024
    Inventor: Thomas VASICEK
  • METHODS AND KITS FOR INDUCING SATIETY AND TREATING METABOLIC DISORDERS
    Publication number: 20240285729
    Abstract: The invention provides methods and kits for inducing satiety and treatment of metabolic disorders, diabetes, obesity, and obesity-related conditions. The methods and kits herein described include administration of a metabolic hormone and a GLP-1 receptor agonist for inducing satiety or treatment of metabolic syndrome, diabetes, obesity, and obesity-related disorders.
    Type: Application
    Filed: June 24, 2022
    Publication date: August 29, 2024
    Inventor: Thomas VASICEK
  • Peptide YY pharmaceutical formulations, compositions, and methods
    Patent number: 11911445
    Abstract: Pharmaceutical compositions comprising PYY (e.g., PYY(3-36) and analogs and variants thereof), satiety peptides, satiety hormones, metabolic hormones, and methods of treating metabolic diseases with such compositions are provided. Aspects include methods of increasing a feeling of fullness in patients treated with pharmaceutical compositions comprising PYY, PYY(3-36), satiety peptides, satiety hormones, metabolic hormones, and analogs, receptor antagonists and variants thereof.
    Type: Grant
    Filed: January 23, 2019
    Date of Patent: February 27, 2024
    Assignee: Gila Therapeutics, Inc.
    Inventors: Andres Acosta, Thomas Vasicek, Beth Anne-Szkudlarek Brown
  • COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES
    Publication number: 20230084803
    Abstract: Compositions comprising satiety peptides (e.g., PYY, PYY(3-36), GLP-1, oxyntomodulin, and cholecystokinin) and DPP-IV inhibitors and methods of treating metabolic diseases with such compositions are provided.
    Type: Application
    Filed: April 27, 2022
    Publication date: March 16, 2023
    Inventors: Andres ACOSTA, Thomas VASICEK
  • PEPTIDE YY PHARMACEUTICAL FORMULATIONS, COMPOSITIONS, AND METHODS
    Publication number: 20220143146
    Abstract: Pharmaceutical compositions comprising PYY (e.g., PYY(3-36) and analogs and variants thereof), satiety peptides, satiety hormones, metabolic hormones, and methods of treating metabolic diseases with such compositions are provided. Aspects include methods of increasing a feeling of fullness in patients treated with pharmaceutical compositions comprising PYY, PYY(3-36), satiety peptides, satiety hormones, metabolic hormones, and analogs, receptor antagonists and variants thereof.
    Type: Application
    Filed: June 1, 2021
    Publication date: May 12, 2022
    Inventors: Andres ACOSTA, Thomas VASICEK, Beth Anne-Szkudlarek BROWN
  • PEPTIDE YY PHARMACEUTICAL FORMULATIONS, COMPOSITIONS, AND METHODS
    Publication number: 20210308223
    Abstract: Pharmaceutical compositions comprising PYY (e.g., PYY(3-36) and analogs and variants thereof), satiety peptides, satiety hormones, metabolic hormones, and methods of treating metabolic diseases with such compositions are provided. Aspects include methods of increasing a feeling of fullness in patients treated with pharmaceutical compositions comprising PYY, PYY(3-36), satiety peptides, satiety hormones, metabolic hormones, and analogs, receptor antagonists and variants thereof.
    Type: Application
    Filed: June 1, 2021
    Publication date: October 7, 2021
    Inventors: Andres ACOSTA, Thomas VASICEK, Beth Anne-Szkudlarek BROWN
  • Peptide YY Pharmaceutical Formulations, Compositions, and Methods
    Publication number: 20190231850
    Abstract: Pharmaceutical compositions comprising PYY (e.g., PYY(3-36) and analogs and variants thereof), satiety peptides, satiety hormones, metabolic hormones, and methods of treating metabolic diseases with such compositions are provided. Aspects include methods of increasing a feeling of fullness in patients treated with pharmaceutical compositions comprising PYY, PYY(3-36), satiety peptides, satiety hormones, metabolic hormones, and analogs, receptor antagonists and variants thereof.
    Type: Application
    Filed: January 23, 2019
    Publication date: August 1, 2019
    Inventors: Andres ACOSTA, Thomas VASICEK, Beth Anne-Szkudlarek BROWN
  • Compositions and Methods for Treating Metabolic Diseases
    Publication number: 20190224280
    Abstract: Compositions comprising satiety peptides (e.g., PYY, PYY(3-36), GLP-1, oxyntomodulin, and cholecystokinin) and DPP-IV inhibitors and methods of treating metabolic diseases with such compositions are provided.
    Type: Application
    Filed: January 9, 2019
    Publication date: July 25, 2019
    Inventors: Andres ACOSTA, Thomas VASICEK